U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Inspections, Compliance, Enforcement, and Criminal Investigations
  3. Compliance Actions and Activities
  4. Warning Letters
  5. Quality Dairy Company - 614395 - 04/23/2021
  1. Warning Letters

CLOSEOUT LETTER

Quality Dairy Company MARCS-CMS 614395 —

Delivery Method:
VIA UPS
Reference #:
FY20-HAFE6-03
Product:
Food & Beverages

Recipient:
Recipient Name
Mr. Ken Martin
Recipient Title
President
Quality Dairy Company

1335 Diamond Reo Way
Lansing, MI 48910-1464
United States

Issuing Office:
Division of Human and Animal Food Operations East VI

United States


Dear Mr. Martin:

The Food and Drug Administration has completed evaluation of your firm’s corrective actions in response to our Warning Letter FY20-HAFE6-03 dated May 13, 2020. Based on our evaluation, it appears that you have addressed the violation(s) contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.

This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.

Sincerely,
/S/
Audrey De La Cruz
Acting Compliance Branch Director,
FDA/ORA/OHAFO East-6

Back to Top